InKemia IUCT Group SA (IKM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:InKemia IUCT Group SA (IKM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9437
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InKemia IUCT Group SA (InKemia IUCT), formerly Institut Univ De Ciencia i Technology SA, is a biotechnology company. The company provides research and development, technological, and consulting services. It offers customized research services. InKemia IUCT provides technology services such as physical-chemical analysis and microbiology control services, quality consulting, scientific and technical consultancy, occupational safety and health/environment, and legal auditing services for occupational risk prevention. The company’s technology services also include contract pharmaceutical manufacturing services comprising manufacturing and control services for pharmaceutical products; and active pharmaceutical ingredients production services. The company serves chemical, pharmaceutical, biotechnology, cosmetic, and food and related industries. It operates offices in Mollet del Valles, Tres Cantos and Vilanova i la Geltru, Spain. InKemia IUCT is headquartered in Mollet del Valles, Spain.

InKemia IUCT Group SA (IKM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InKemia IUCT Group SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
InKemia IUCT Group SA, Medical Devices Deals, 2012 to YTD 2018 9
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Myogem Health Company May Raise up to USD0.57 Million in Venture Financing 11
Partnerships 12
1nkemia IUCT Forms Joint Venture with Bionos Biotech 12
Equity Offering 13
1nkemia IUCT to Raise USD2.5 Million in Public Offering of Shares 13
InKemia IUCT Completes IPO 14
Acquisition 15
IUCT Empren Sells BioDan Sciences for USD0.2 Million 15
InKemia IUCT Group SA – Key Competitors 16
InKemia IUCT Group SA – Key Employees 17
InKemia IUCT Group SA – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InKemia IUCT Group SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InKemia IUCT Group SA, Deals By Therapy Area, 2012 to YTD 2018 8
InKemia IUCT Group SA, Medical Devices Deals, 2012 to YTD 2018 9
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Myogem Health Company May Raise up to USD0.57 Million in Venture Financing 11
1nkemia IUCT Forms Joint Venture with Bionos Biotech 12
1nkemia IUCT to Raise USD2.5 Million in Public Offering of Shares 13
InKemia IUCT Completes IPO 14
IUCT Empren Sells BioDan Sciences for USD0.2 Million 15
InKemia IUCT Group SA, Key Competitors 16
InKemia IUCT Group SA, Key Employees 17
InKemia IUCT Group SA, Other Locations 18
InKemia IUCT Group SA, Subsidiaries 18

List of Figures
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
InKemia IUCT Group SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[InKemia IUCT Group SA (IKM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Intarcia Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Intarcia Therapeutics Inc (Intarcia), formerly BioMedicines Inc, is a biopharmaceutical company that focuses on the development of therapies through its proprietary Medici Drug Delivery System, a subcutaneous delivery system to treat chronic conditions. The company’s product candidate includ …
  • Information Analysis Inc (IAIC):企業の財務・戦略的SWOT分析
    Summary Information Analysis Inc (IAI) is a technology company that offers technical solutions. The company offers IT services such as legacy mainframe modernization, database conversion and migration, electronic forms conversion, ebusiness and web based solutions, integrated tablet and mobile appli …
  • Toyo Tire & Rubber Co Ltd (5105):企業の財務・戦略的SWOT分析
    Toyo Tire & Rubber Co Ltd (5105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Pulmonx Corp:医療機器:M&Aディール及び事業提携情報
    Summary Pulmonx Corp (Pulmonx) is a medical device company that manufactures and markets minimally invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders. The company uses combination of assessment tools and therapeutics which enables physicians to successfu …
  • Trevena Inc (TRVN)-製薬・医療分野:企業M&A・提携分析
    Summary Trevena Inc (Trevena) is a biopharmaceutical company that discovers and develops G-protein coupled receptor targeted medicines. The company’s products include RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination with …
  • Altana AG:企業の戦略的SWOT分析
    Altana AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Endotronix Inc-医療機器分野:企業M&A・提携分析
    Summary Endotronix Inc (Endotronix) is a medical device company that provides digital health solutions. The company offers wireless health monitoring solutions to congestive heart failure patients. It develops endotronix care management solution to communicate pressures that accurately measure cardi …
  • Soligenix Inc (SNGX):製薬・医療:M&Aディール及び事業提携情報
    Summary Soligenix Inc (Soligenix) is a late-stage biopharmaceutical company which focuses on the development of products for the treatment of serious inflammatory diseases and biodefense counter measures. It develops biotherapeutics for the treatment of orphan diseases such as cutaneous T-cell lymph …
  • Amil Assistencia Medica Internacional S/A:企業の戦略・SWOT・財務情報
    Amil Assistencia Medica Internacional S/A - Strategy, SWOT and Corporate Finance Report Summary Amil Assistencia Medica Internacional S/A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Mears Group PLC (MER):企業の財務・戦略的SWOT分析
    Summary Mears Group PLC (Mears) is a housing and social care provider. The company offers repairs, rapid response and planned maintenance services for a portfolio of social homes. It provides housing services such as new homes, energy services, housing management, home improvement, branches, planned …
  • Campbell Soup Company:企業の戦略・SWOT・財務分析
    Campbell Soup Company - Strategy, SWOT and Corporate Finance Report Summary Campbell Soup Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Konica Minolta Inc (4902):医療機器:M&Aディール及び事業提携情報
    Summary Konica Minolta, Inc. (Konica Minolta) develops, manufactures and sells printing systems and solutions for production print professionals. The company’s product portfolio includes multi-functional peripherals (MFPs), printers, equipment for production print systems and graphic arts, equipment …
  • Wirtgen GmbH:企業の戦略・SWOT・財務情報
    Wirtgen GmbH - Strategy, SWOT and Corporate Finance Report Summary Wirtgen GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Microchip Technology Incorporated (MCHP):企業の財務・戦略的SWOT分析
    Microchip Technology Incorporated (MCHP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Arbor Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Arbor Pharmaceuticals LLC (Arbor) is a healthcare products provider that develops prescription products for the hospital, cardiovascular and pediatric segments. The company offers licensing, manufacturing, development and commercialization of late-stage prescription products. It also offers …
  • CGG SA (CGG):石油・ガス:M&Aディール及び事業提携情報
    Summary CGG SA (CGG) is an integrated geoscience service company. It provides a wide range of data acquisition, processing, and interpretation services. The company also provides related imaging and interpretation software to clients in the oil and gas exploration and production business. CGG offers …
  • Fanuc Corp (6954)
    Fanuc Corp (6954) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • University of Aberdeen:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Aberdeen (UOA) is an educational and research institution that offers educational and research programs. The university offers undergraduate, graduate, postgraduate and research programs. It provides undergraduate and postgraduate courses in the areas of education, creative art …
  • Patrys Ltd (PAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Patrys Ltd (Patrys) is a therapeutic antibody development company focused on IgM antibodies and IgG antibody fragments in the field of oncology. The company's pipeline products include PAT-SC1 an immunoglobulin M (IgM) type antibody used for the treatment of gastric cancer; PAT-SM6 is a full …
  • Henry Ford Health System:企業の戦略的SWOT分析
    Henry Ford Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆